Tmprss11g, a transmembrane protease predicted to possess serine-type endopeptidase activity, plays a crucial role in cellular proteolysis. The function of this target involves the cleavage of specific substrates, a process essential for various cellular activities. Its serine-type endopeptidase activity suggests involvement in the regulation of protein function through precise cleavage events, potentially influencing downstream signaling cascades and cellular processes. Located on the plasma membrane, Tmprss11g is strategically positioned to engage with extracellular or membrane-bound substrates, contributing to the intricate web of cellular proteolytic events. The general mechanisms governing the activation of Tmprss11g are orchestrated by a diverse array of chemical activators. These activators act through different pathways and processes to enhance the serine-type endopeptidase activity of Tmprss11g. Some directly activate the target by stabilizing its presence on the plasma membrane, preventing its degradation, and consequently increasing the levels of active Tmprss11g. Others act indirectly by modulating cellular pathways, such as inhibiting the proteasome or specific kinases, leading to the up-regulation of Tmprss11g activity. The specificity of these activators lies in their ability to influence serine-type endopeptidase activity, contributing to the intricate regulatory network of cellular proteolysis.
Understanding the mechanisms of Tmprss11g activation sheds light on its role in maintaining cellular homeostasis through precise control of proteolytic processes. The intricate interplay between chemical activators and Tmprss11g highlights the sophistication of cellular signaling networks. As a transmembrane protease, Tmprss11g stands at the crossroads of various cellular events, participating in the regulation of substrate cleavage and subsequent cellular responses. This comprehensive understanding of Tmprss11g and its activation mechanisms contributes to the broader comprehension of cellular proteolysis, paving the way for future exploration of its functional significance in various physiological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid directly activates Tmprss11g by binding to retinoic acid receptors (RARs) on the plasma membrane. This complex induces proteolysis, enhancing serine-type endopeptidase activity. The up-regulation of Tmprss11g contributes to increased proteolytic activity, strengthening cellular processes involving substrate cleavage and promoting the target's function. | ||||||
Thrombin from human plasma | 9002-04-4 | sc-471713 | 100 U | $235.00 | ||
Thrombin stimulates Tmprss11g through the activation of protease-activated receptors (PARs) on the plasma membrane. PAR activation triggers intracellular signaling cascades, leading to enhanced serine-type endopeptidase activity. This up-regulation of Tmprss11g amplifies proteolytic processes, influencing cellular functions associated with proteolysis and promoting the target's activation. | ||||||
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $43.00 $183.00 $312.00 $624.00 $2081.00 $4474.00 | 5 | |
Camostat mesylate directly activates Tmprss11g as a serine protease inhibitor. By inhibiting serine protease activity, it prevents the degradation of Tmprss11g, leading to increased protein levels on the plasma membrane. This up-regulation enhances serine-type endopeptidase activity, influencing proteolytic processes and promoting the target's function. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
Nafamostat mesylate is a serine protease inhibitor that directly activates Tmprss11g. By inhibiting serine protease activity, it stabilizes Tmprss11g on the plasma membrane, promoting increased serine-type endopeptidase activity. This up-regulation influences proteolytic processes, amplifying cellular functions associated with substrate cleavage and promoting the target's activation. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin indirectly activates Tmprss11g by inhibiting the proteasome pathway. By blocking proteasome-mediated degradation, it stabilizes Tmprss11g levels on the plasma membrane, leading to increased serine-type endopeptidase activity. This up-regulation influences proteolytic processes, promoting cellular functions associated with substrate cleavage and enhancing the target's activation. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64d is a cysteine protease inhibitor that indirectly activates Tmprss11g. By inhibiting cysteine protease activity, it prevents the degradation of Tmprss11g, leading to increased serine-type endopeptidase activity. This up-regulation influences proteolytic processes, promoting cellular functions associated with substrate cleavage and enhancing the target's activation on the plasma membrane. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin directly activates Tmprss11g as a serine protease inhibitor. By inhibiting serine protease activity, it stabilizes Tmprss11g levels on the plasma membrane, leading to increased serine-type endopeptidase activity. This up-regulation influences proteolytic processes, promoting cellular functions associated with substrate cleavage and enhancing the target's activation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib indirectly activates Tmprss11g by inhibiting the proteasome pathway. By blocking proteasome-mediated degradation, it stabilizes Tmprss11g levels on the plasma membrane, leading to increased serine-type endopeptidase activity. This up-regulation influences proteolytic processes, promoting cellular functions associated with substrate cleavage and enhancing the target's activation. | ||||||